Total Payments
$35,221
2024 Payments
$1,664
Companies
50
Transactions
721
Medicare Patients
7,278
Medicare Billing
$998,173
Payment Breakdown by Category
Food & Beverage$16,167 (45.9%)
Other$15,315 (43.5%)
Travel$3,009 (8.5%)
Education$729.81 (2.1%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $16,167 | 675 | 45.9% |
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $15,315 | 8 | 43.5% |
| Travel and Lodging | $3,009 | 23 | 8.5% |
| Education | $729.81 | 15 | 2.1% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Sunovion Pharmaceuticals Inc. | $19,566 | 69 | $0 (2020) |
| AstraZeneca Pharmaceuticals LP | $2,143 | 75 | $0 (2024) |
| GlaxoSmithKline, LLC. | $1,781 | 107 | $0 (2024) |
| JAZZ PHARMACEUTICALS INC. | $1,659 | 44 | $0 (2024) |
| Janssen Pharmaceuticals, Inc | $1,246 | 31 | $0 (2022) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $1,152 | 68 | $0 (2024) |
| Insmed, Inc. | $1,043 | 35 | $0 (2024) |
| Grifols USA, LLC | $720.20 | 31 | $0 (2023) |
| PFIZER INC. | $666.22 | 16 | $0 (2024) |
| GENZYME CORPORATION | $542.73 | 19 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $1,664 | 59 | AstraZeneca Pharmaceuticals LP ($317.74) |
| 2023 | $2,053 | 87 | AstraZeneca Pharmaceuticals LP ($268.66) |
| 2022 | $2,254 | 101 | AstraZeneca Pharmaceuticals LP ($299.16) |
| 2021 | $2,343 | 89 | AstraZeneca Pharmaceuticals LP ($551.03) |
| 2020 | $1,288 | 52 | Janssen Pharmaceuticals, Inc ($228.84) |
| 2019 | $2,189 | 91 | GlaxoSmithKline, LLC. ($328.76) |
| 2018 | $11,292 | 110 | Sunovion Pharmaceuticals Inc. ($9,052) |
| 2017 | $12,136 | 132 | Sunovion Pharmaceuticals Inc. ($10,424) |
All Payment Transactions
721 individual payment records from CMS Open Payments — Page 1 of 29
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/20/2024 | Ethicon Inc. | Monarch Platform (Device) | Food and Beverage | In-kind items and services | $21.70 | General |
| Category: Endo-Mechanical | ||||||
| 12/17/2024 | Insmed, Inc. | Arikayce (Drug) | Food and Beverage | In-kind items and services | $32.34 | General |
| Category: Respiratory | ||||||
| 12/13/2024 | GENZYME CORPORATION | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $27.80 | General |
| Category: Immunology | ||||||
| 11/27/2024 | Avadel CNS Pharmaceuticals, LLC | LUMRYZ (Drug) | Food and Beverage | In-kind items and services | $22.70 | General |
| Category: CENTRAL NERVOUS SYSTEM CNS NEUROLOGY | ||||||
| 11/27/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug), BREZTRI | Education | In-kind items and services | $22.52 | General |
| Category: Respiratory | ||||||
| 11/26/2024 | Insmed, Inc. | Arikayce (Drug) | Food and Beverage | In-kind items and services | $32.34 | General |
| Category: Respiratory | ||||||
| 11/14/2024 | GENZYME CORPORATION | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $33.93 | General |
| Category: Immunology | ||||||
| 11/08/2024 | Philips North America LLC | (AK6) Vest Therapy (Device) | Food and Beverage | Cash or cash equivalent | $18.86 | General |
| Category: Medical Device | ||||||
| 11/05/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $13.29 | General |
| Category: RESPIRATORY | ||||||
| 10/21/2024 | GENZYME CORPORATION | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $25.99 | General |
| Category: Immunology | ||||||
| 10/14/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | — | Food and Beverage | In-kind items and services | $33.63 | General |
| 10/09/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $14.43 | General |
| Category: Respiratory | ||||||
| 10/08/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $20.73 | General |
| Category: RESPIRATORY | ||||||
| 10/07/2024 | Phathom Pharmaceuticals, Inc. | VOQUEZNA (Drug) | Food and Beverage | In-kind items and services | $19.60 | General |
| Category: GASTROENTEROLOGY | ||||||
| 10/07/2024 | GENZYME CORPORATION | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $4.06 | General |
| Category: Immunology | ||||||
| 10/03/2024 | AstraZeneca Pharmaceuticals LP | FASENRA (Biological) | Food and Beverage | In-kind items and services | $17.05 | General |
| Category: Respiratory | ||||||
| 09/11/2024 | Insmed, Inc. | Arikayce (Drug) | Food and Beverage | In-kind items and services | $29.37 | General |
| Category: Respiratory | ||||||
| 09/10/2024 | Avadel CNS Pharmaceuticals, LLC | LUMRYZ (Drug) | Food and Beverage | In-kind items and services | $21.88 | General |
| Category: CENTRAL NERVOUS SYSTEM CNS NEUROLOGY | ||||||
| 09/03/2024 | Exact Sciences Corporation | Cologuard Collection Kit (Device) | Food and Beverage | In-kind items and services | $79.40 | General |
| Category: Oncology | ||||||
| 08/21/2024 | Actelion Pharmaceuticals US, Inc. | OPSUMIT (Drug), UPTRAVI | Food and Beverage | In-kind items and services | $22.40 | General |
| Category: Cardiology | ||||||
| 07/31/2024 | Mallinckrodt Hospital Products Inc. | ACTHAR (Biological) | Food and Beverage | In-kind items and services | $20.45 | General |
| Category: IMMUNOLOGY | ||||||
| 07/30/2024 | Insmed, Inc. | Arikayce (Drug) | Food and Beverage | In-kind items and services | $29.70 | General |
| Category: Respiratory | ||||||
| 07/17/2024 | GENZYME CORPORATION | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $16.43 | General |
| Category: Immunology | ||||||
| 07/02/2024 | Itamar Medical Inc | WatchPATONE (Device) | Food and Beverage | Cash or cash equivalent | $52.90 | General |
| Category: Sleep Apnea testing | ||||||
| 07/01/2024 | AstraZeneca Pharmaceuticals LP | TEZSPIRE (Biological) | Food and Beverage | In-kind items and services | $26.44 | General |
| Category: Respiratory | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 25 | 1,557 | 2,864 | $521,004 | $235,474 |
| 2022 | 28 | 1,608 | 2,976 | $494,137 | $229,035 |
| 2021 | 31 | 1,823 | 3,480 | $544,914 | $258,991 |
| 2020 | 37 | 2,290 | 4,069 | $625,083 | $274,673 |
Total Patients
7,278
Total Services
13,389
Medicare Billing
$998,173
Procedure Codes
124
All Medicare Procedures & Services
124 procedure records from CMS Medicare Utilization — Page 1 of 5
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 420 | 1,470 | $248,451 | $130,100 | 52.4% |
| 99497 | Advance care planning, first 30 minutes | Office | 2023 | 250 | 303 | $45,450 | $20,205 | 44.5% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 93 | 150 | $35,100 | $19,424 | 55.3% |
| 95811 | Sleep study in sleep lab with continuous airway pressure (6 years or older) | Office | 2023 | 26 | 50 | $59,350 | $13,629 | 23.0% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2023 | 91 | 91 | $18,200 | $10,898 | 59.9% |
| 95810 | Sleep study in sleep lab (6 years or older) | Office | 2023 | 21 | 40 | $40,650 | $10,108 | 24.9% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 66 | 66 | $16,500 | $8,155 | 49.4% |
| 99495 | Transitional care management services for problem of at least moderate complexity | Office | 2023 | 21 | 22 | $4,400 | $3,350 | 76.1% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 16 | 50 | $5,000 | $2,993 | 59.9% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 31 | 42 | $5,250 | $2,375 | 45.2% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2023 | 15 | 15 | $4,433 | $2,357 | 53.2% |
| 94060 | Test to measure expiratory airflow and volume changes before and after medication administration | Office | 2023 | 66 | 70 | $7,000 | $1,832 | 26.2% |
| G0442 | Annual alcohol misuse screening, 5 to 15 minutes | Office | 2023 | 99 | 99 | $2,475 | $1,691 | 68.3% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2023 | 39 | 40 | $2,520 | $1,680 | 66.7% |
| G0444 | Annual depression screening, 5 to 15 minutes | Office | 2023 | 98 | 98 | $2,499 | $1,674 | 67.0% |
| G0180 | Physician or allowed practitioner certification for medicare-covered home health services under a home health plan of care (patient not present), including contacts with home health agency and review of reports of patient status required by physicians and | Office | 2023 | 27 | 40 | $3,200 | $1,555 | 48.6% |
| 94618 | Test for exercise-induced lung stress | Office | 2023 | 37 | 38 | $5,700 | $946.73 | 16.6% |
| G0179 | Physician or allowed practitioner re-certification for medicare-covered home health services under a home health plan of care (patient not present), including contacts with home health agency and review of reports of patient status required by physicians a | Office | 2023 | 15 | 24 | $1,680 | $704.26 | 41.9% |
| 99406 | Smoking and tobacco use intensive counseling, 4-10 minutes | Office | 2023 | 30 | 41 | $2,425 | $569.90 | 23.5% |
| 95806 | Sleep study including heart rate, breathing, airflow, and effort | Office | 2023 | 14 | 15 | $4,500 | $465.36 | 10.3% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2023 | 12 | 29 | $725.00 | $294.28 | 40.6% |
| 94726 | Test to determine lung volumes using sensors | Facility | 2023 | 18 | 18 | $1,323 | $153.68 | 11.6% |
| 93010 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | Facility | 2023 | 20 | 21 | $1,260 | $123.20 | 9.8% |
| 94010 | Test to measure expiratory airflow and volume | Facility | 2023 | 19 | 19 | $1,900 | $110.88 | 5.8% |
| 94729 | Test to examine how well the lungs exchange gases | Facility | 2023 | 13 | 13 | $1,014 | $80.28 | 7.9% |
About Dr. Robert Thomas, MD
Dr. Robert Thomas, MD is a Critical Care Medicine healthcare provider based in Walterboro, South Carolina. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 01/25/2006. The National Provider Identifier (NPI) number assigned to this provider is 1750351508.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Robert Thomas, MD has received a total of $35,221 in payments from pharmaceutical and medical device companies, with $1,664 received in 2024. These payments were reported across 721 transactions from 50 companies. The most common payment nature is "Food and Beverage" ($16,167).
As a Medicare-enrolled provider, Thomas has provided services to 7,278 Medicare beneficiaries, totaling 13,389 services with total Medicare billing of $998,173. Data is available for 4 years (2020–2023), covering 124 distinct procedure/service records.
Ad
Practice Information
- Specialty Critical Care Medicine
- Other Specialties Pulmonary Disease, Sleep Medicine
- Location Walterboro, SC
- Active Since 01/25/2006
- Last Updated 10/10/2024
- Taxonomy Code 207RC0200X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1750351508
Products in Payments
- UTIBRON (Drug) $16,064
- LONHALA MAGNAIR (Drug) $3,483
- TRELEGY ELLIPTA (Drug) $1,115
- XARELTO (Drug) $1,089
- Arikayce (Drug) $1,043
- XYWAV (Drug) $680.76
- OFEV (Drug) $652.29
- FARXIGA (Drug) $649.24
- Prolastin-C Liquid (Biological) $549.93
- ELIQUIS (Drug) $507.13
- ACTHAR (Biological) $440.81
- SUNOSI (Drug) $413.26
- DUPIXENT (Biological) $380.11
- Xyrem (Drug) $361.54
- BREZTRI (Drug) $357.89
- Sunosi (Drug) $348.99
- FASENRA (Biological) $300.76
- GLASSIA (Biological) $275.72
- STIOLTO RESPIMAT (Drug) $274.67
- ANORO (Drug) $260.79
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.